UCB Obtains European Antitrust Clearance for Take-Over of SCHWARZ PHARMA
Advertisement
UCB announced that the EU Commission has cleared the proposed take-over of SCHWARZ PHARMA by UCB. As announced on November 10, 2006, the U.S. Federal Trade Commission (FTC) has allowed the waiting period to expire without expressing any concerns. Therefore, the take-over of SCHWARZ PHARMA by UCB can be pursued both from a European and U.S. antitrust perspective.
UCB announced the commencement of the acceptance period for the take-over of SCHWARZ PHARMA which is from November 10, 2006 until December 8, 2006, 24:00 hours (CET). On November 20, 2006, the Executive Board and Supervisory Board of the SCHWARZ PHARMA AG recommended acceptance of the offer by UCB to the shareholders of SCHWARZ PHARMA AG.
Most read news
Organizations
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Chevron Moving Corporate Headquarters to San Ramon, Calif.

Topping Out Ceremony for the 30 MW Pressurized Alkaline Electrolyser Building at the Bad Lauchstädt Energy Park
Analytik Jena Opens Swiss Branch Office at the Endress+Hauser Headquarters
List_of_biotechnology_companies
Plant Impact plc Signs R&D Collaboration Agreement with CEM Analytical Services Ltd and tecsolve (UK) Ltd
BASF raises formic acid production capacity

Superior light-to-chemical energy conversion with Coulombic dyads - Scientists established a novel photocatalyst class that uses precious metals more efficiently
Johnson & Johnson to Merge with ALZA Corporation In $10.5 Billion Stock-for-Stock Transaction
Merck KGaA and Jerini Announce Collaboration to Develop Small Molecule Cancer Drugs
GLOBAL BIOENERGIES and AUDI continue partnership in renewable gasoline
A new look at high-temperature superconductors
